Metropolitan Life Insurance CO Cullinan Oncology, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$8.8 - $13.4 $4,426 - $6,740	-503 Reduced 28.12%	1,286 $13,000
Q1 2023 May 15, 2023	SELL	$10.2 - $11.91 $2,009 - $2,346	-197 Reduced 9.92%	1,789 $18,000
Q4 2022 Jun 14, 2023	BUY	$9.72 - $13.62 $1,914 - $2,683	197 Added 11.01%	1,986 $21 Million
Q4 2022 Mar 30, 2023	BUY	$9.72 - $13.62 $1,516 - $2,124	156 Added 8.52%	1,986 $20,000
Q4 2022 Feb 15, 2023	BUY	$9.72 - $13.62 $1,516 - $2,124	156 Added 8.52%	1,986 $20,000
Q3 2022 Jun 14, 2023	BUY	$11.82 - $15.42 $484 - $632	41 Added 2.29%	1,830 $23.5 Million
Q2 2022 Jun 20, 2023	BUY	$7.31 - $13.55 $299 - $555	41 Added 2.29%	1,830 $23,000
Q1 2022 Jun 20, 2023	BUY	$10.47 - $16.75 $429 - $686	41 Added 2.29%	1,830 $19,000
Q1 2022 Mar 30, 2023	SELL	$10.47 - $16.75 $58,527 - $93,632	-5,590 Reduced 75.34%	1,830 $19,000
Q1 2022 May 12, 2022	SELL	$10.47 - $16.75 $58,527 - $93,632	-5,590 Reduced 75.34%	1,830 $19,000
Q4 2021 Jun 21, 2023	BUY	$15.36 - $25.0 $86,492 - $140,775	5,631 Added 314.76%	7,420 $114,000
Q3 2021 Jun 21, 2023	BUY	$22.56 - $29.68 $127,035 - $167,128	5,631 Added 314.76%	7,420 $167,000
Q3 2021 Mar 30, 2023	BUY	$22.56 - $29.68 $54,550 - $71,766	2,418 Added 48.34%	7,420 $167,000
Q3 2021 Nov 15, 2021	BUY	$22.56 - $29.68 $54,550 - $71,766	2,418 Added 48.34%	7,420 $167,000
Q2 2021 Jun 21, 2023	BUY	$24.96 - $41.25 $80,196 - $132,536	3,213 Added 179.6%	5,002 $128,000
Q2 2021 Mar 30, 2023	BUY	$24.96 - $41.25 $13,603 - $22,481	545 Added 12.23%	5,002 $128,000
Q2 2021 Aug 16, 2021	BUY	$24.96 - $41.25 $124,750 - $206,167	4,998 Added 124950.0%	5,002 $129,000
Q1 2021 Jun 26, 2023	BUY	$28.0 - $53.42 $74,704 - $142,524	2,668 Added 149.13%	4,457 $186 Million
Q1 2021 Mar 30, 2023	BUY	$28.0 - $53.42 $69,188 - $132,000	2,471 Added 124.42%	4,457 $185,000
Q1 2021 May 14, 2021	BUY	$28.0 - $53.42 $112 - $213	4 New	4 $186,000

Others Institutions Holding CGEM

# of Institutions

146

Shares Held

67.6M

Call Options Held

612K

Put Options Held

118K

Bio Impact Capital LLC Cambridge, MA

7.65M
Shares

$103 Million
19.97% of portfolio
Bvf Inc San Francisco, CA

5.75M
Shares

$77.3 Million
3.06% of portfolio
Black Rock Inc. New York, NY

3.55M
Shares

$47.8 Million
0.0% of portfolio
Chi Advisors LLC New York, NY

3.41M
Shares

$45.9 Million
15.23% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

3.28M
Shares

$44.1 Million
1.02% of portfolio

View Full List

About Cullinan Oncology, Inc.

Ticker CGEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,612,200
Market Cap $613M
Description
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...

More about CGEM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account